Literature DB >> 26193421

The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.

Melania E Mercado-Pimentel1, Benjamin C Onyeagucha2, Qing Li3, Angel C Pimentel4, Jana Jandova1, Mark A Nelson5.   

Abstract

S100P signaling through the receptor for advanced glycation end-products (RAGE) contributes to colon cancer invasion and metastasis, but the mechanistic features of this process are obscure. Here, we investigate whether activation of S100P/RAGE signaling regulates oncogenic microRNA-21 (miR-21). We show that exogenous S100P up-regulates miR-21 levels in human colon cancer cells, whereas knockdown of S100P results in a decrease of miR-21. Furthermore, blockage of RAGE with anti-RAGE antibody suppresses S100P induction of miR-21. In addition, we found that S100P induction of miR-21 expression involves ERK and is suppressed by the MEK inhibitor U0126. Also, S100P treatment stimulates the enrichment of c-Fos, and AP-1 family members, at the miR-21 gene promoter.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AP-1; Colon cancer; Inflammation; Metastasis; RAGE; RECK; TCGA; miR-21; microRNAs

Mesh:

Substances:

Year:  2015        PMID: 26193421      PMCID: PMC4582666          DOI: 10.1016/j.febslet.2015.07.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.

Authors:  Melania E Mercado-Pimentel; Antony D Hubbard; Raymond B Runyan
Journal:  Dev Biol       Date:  2006-12-23       Impact factor: 3.582

2.  Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells.

Authors:  Petra Faltejskova; Andrej Besse; Sabina Sevcikova; Lenka Kubiczkova; Marek Svoboda; Jan Smarda; Igor Kiss; Rostislav Vyzula; Ondrej Slaby
Journal:  Int J Colorectal Dis       Date:  2012-04-03       Impact factor: 2.571

3.  Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect.

Authors:  Dominique Elias; Gabriel Liberale; Déwi Vernerey; Marc Pocard; Michel Ducreux; Valérie Boige; David Malka; Jean-Pierre Pignon; Philippe Lasser
Journal:  Ann Surg Oncol       Date:  2005-09-26       Impact factor: 5.344

4.  The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.

Authors:  J Oh; R Takahashi; S Kondo; A Mizoguchi; E Adachi; R M Sasahara; S Nishimura; Y Imamura; H Kitayama; D B Alexander; C Ide; T P Horan; T Arakawa; H Yoshida; S Nishikawa; Y Itoh; M Seiki; S Itohara; C Takahashi; M Noda
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

5.  NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors.

Authors:  Vivian Y Shin; Hongchuan Jin; Enders K O Ng; Alfred S L Cheng; Wilson W S Chong; Christine Y P Wong; Wai K Leung; Joseph J Y Sung; Kent-Man Chu
Journal:  Carcinogenesis       Date:  2010-11-15       Impact factor: 4.944

6.  Management of hepatic metastases from colorectal cancer.

Authors:  Ketan R Sheth; Bryan M Clary
Journal:  Clin Colon Rectal Surg       Date:  2005-08

7.  S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer.

Authors:  Benjamin Chidi Onyeagucha; Melania E Mercado-Pimentel; Jennifer Hutchison; Erik K Flemington; Mark A Nelson
Journal:  Exp Cell Res       Date:  2013-05-18       Impact factor: 3.905

8.  RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways.

Authors:  Maren K Fuentes; Shraddha S Nigavekar; Thiruvengadam Arumugam; Craig D Logsdon; Ann Marie Schmidt; Juliet C Park; Emina H Huang
Journal:  Dis Colon Rectum       Date:  2007-08       Impact factor: 4.585

9.  The induction of S100p expression by the Prostaglandin E₂ (PGE₂)/EP4 receptor signaling pathway in colon cancer cells.

Authors:  Anupama Chandramouli; Melania E Mercado-Pimentel; Anthony Hutchinson; Adriana Gibadulinová; Erik R Olson; Sally Dickinson; Reneé Shañas; Jennifer Davenport; Janae Owens; Achyut K Bhattacharyya; John W Regan; Silvia Pastorekova; Thiruvengadam Arumugam; Craig D Logsdon; Mark A Nelson
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

10.  Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.

Authors:  Zhiyong Shen; Haijun Deng; Yuan Fang; Xianjun Zhu; Geng-Tai Ye; Li Yan; Hao Liu; Guoxin Li
Journal:  Oncotarget       Date:  2015-08-21
View more
  15 in total

1.  Advanced Glycation End Products Stimulate Angiotensinogen Production in Renal Proximal Tubular Cells.

Authors:  Joseph M Garagliano; Akemi Katsurada; Kayoko Miyata; Andrei V Derbenev; Andrea Zsombok; L Gabriel Navar; Ryousuke Satou
Journal:  Am J Med Sci       Date:  2018-10-24       Impact factor: 2.378

2.  Berberine regulates the microRNA-21-ITGΒ4-PDCD4 axis and inhibits colon cancer viability.

Authors:  Yanfeng Lü; Bingbing Han; Hualong Yu; Zhenghua Cui; Zhiwen Li; Jianxin Wang
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

Review 3.  The RAGE/multiligand axis: a new actor in tumor biology.

Authors:  Armando Rojas; Ivan Schneider; Cristian Lindner; Ileana Gonzalez; Miguel A Morales
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

4.  In vitro anticancer effects of a RAGE inhibitor discovered using a structure-based drug design system.

Authors:  Ali Hafez Ali Mohammed El-Far; Seiichi Munesue; Ai Harashima; Akira Sato; Mika Shindo; Shingo Nakajima; Mana Inada; Mariko Tanaka; Akihiko Takeuchi; Hiroyuki Tsuchiya; Hiroshi Yamamoto; Hazem M E Shaheen; Yasser S El-Sayed; Shuhei Kawano; Sei-Ichi Tanuma; Yasuhiko Yamamoto
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

Review 5.  Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.

Authors:  Salvatore Bongarzone; Vilius Savickas; Federico Luzi; Antony D Gee
Journal:  J Med Chem       Date:  2017-05-19       Impact factor: 7.446

Review 6.  Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression.

Authors:  Ali H El-Far; Grazyna Sroga; Soad K Al Jaouni; Shaker A Mousa
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 7.  AGE-RAGE synergy influences programmed cell death signaling to promote cancer.

Authors:  Bhargav N Waghela; Foram U Vaidya; Kishu Ranjan; Abu Sufiyan Chhipa; Budhi Sagar Tiwari; Chandramani Pathak
Journal:  Mol Cell Biochem       Date:  2020-10-06       Impact factor: 3.396

Review 8.  Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia.

Authors:  T Grega; G Vojtechova; M Gregova; M Zavoral; S Suchanek
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

9.  S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.

Authors:  Kyoko Kikuchi; Keely May McNamara; Yasuhiro Miki; Erina Iwabuchi; Ayako Kanai; Minoru Miyashita; Takanori Ishida; Hironobu Sasano
Journal:  Cell Oncol (Dordr)       Date:  2018-09-22       Impact factor: 7.051

10.  Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.

Authors:  Zhigui Zuo; Peili Zhang; Feiyan Lin; Wenjing Shang; Ruichun Bi; Fengying Lu; Jianbo Wu; Lei Jiang
Journal:  J Cell Mol Med       Date:  2018-01-31       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.